✦ LIBER ✦

Long term follow-up of CEOP in the treatment of HIV related non-Hodgkin's lymphoma (NHL)

✍ Scribed by Davis, A. J. ;Goldstein, D. ;Milliken, S.

Book ID: 108999984
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 461 KB
Volume: 28
Category: Article
ISSN: 0004-8291
DOI: 10.1111/j.1445-5994.1998.tb04455.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LONG-TERM SURVIVAL OF PATIENTS WITH HIV-

LONG-TERM SURVIVAL OF PATIENTS WITH HIV-RELATED SYSTEMIC NON-HODGKIN'S LYMPHOMAS

✍ UMBERTO TIRELLI; DOMENICO ERRANTE; MICHELE SPINA; EMANUELA VACCHER; DIEGO SERRAI 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 604 KB

Background: the overall outcome of patients with HIV-related non-Hodgkin's lymphomas (HIV-NHL) is poor because of the adverse clinico-pathological features of HIV-NHL and of the underlying HIV infection. However, the experience of physicians in the management of HIV-NHL has increased, in particular

Increase in the incidence of non-Hodgkin

Increase in the incidence of non-Hodgkin’s lymphoma, clinical features and long-term follow-up

✍ Marta Llanos Muñoz; Remedios Alemán Wallss; Hugo Álvarez-Argüelles Cabrera; Fran 📂 Article 📅 2001 🏛 Springer Milan 🌐 Spanish ⚖ 70 KB

Long-term follow-up of allogeneic bone m

Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin’s lymphoma

✍ Bernard, M; Dauriac, C; Drénou, B; Leberre, C; Branger, B; Fauchet, R; Le Prisé, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 49 KB

What is the Price of survival in Hodgkin

What is the Price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients

✍ Miltényi Zsófia; Keresztes Katalin; Végh Judit; Székely György; Illés Árpád 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

## Abstract The paper investigates the late complications of cured Hodgkin's lymphoma (HL) patients. Ninety cured HL patients between 1975 and 1994 were examined. The mean ages of patients at the time of diagnosing HL, and the median period of survival after diagnosis were 32 (11–70) years and 18 (

Long term follow-up and late complicatio

Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-hodgkin's lymphoma

✍ Lynn R. Kong; Cheng-Fang Huang; David Hakimian; Daina Variakojis; Leonard Klein; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

## Background: The aim of this study was to determine the long term outcome and toxicities after the administration of 2-chlorodeoxyadenosine (2-cda) to patients with previously treated, advanced, indolent non-hodgkin's lymphoma (nhl). ## Methods: Twenty-two patients (median age, 55 years) with r

Long term follow-up and late complicatio

Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma

✍ Meral Beksaç; Mutlu Arat; Ramazan Idilman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

Is Flow Cytometry a Useful Test? R epresenting a busy flow cytometry laboratory with an annual workload of approximately 1400 acute leukemia and malignant lymphoma cases, we read the article by Naughton et al. 1 with considerable interest. The authors concluded that "flow cytometry of bone marrow as